1188PDMargetuximab (M) + pembrolizumab (P) for treatment of...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1188PDMargetuximab (M) + pembrolizumab (P) for treatment of patients (pts) with HER2+ gastroesophageal adenocarcinoma (GEA) post-trastuzumab (T): Survival analysis

Catenacci, D V, Park, H, Uronis, H, Kang, Y-K, Ng, M C H, Enzinger, P, Lee, K W, Lim, K H, Gold, P J, Lacy, J, Park, S H, Huber, K, Wynter-Horton, A, Nordstrom, J, Wu, T, Wigginton, J, Baughman, J, Ro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz253.014
Date:
October, 2019
File:
PDF, 89 KB
2019
Conversion to is in progress
Conversion to is failed